Reuters
Published Jul 11, 2022 10:21
Updated Jul 11, 2022 10:55
By Natalie Grover and Francesco Guarascio
BRUSSELS/LONDON (Reuters) -European Union health agencies on Monday recommended a second COVID-19 booster for everyone over 60, as well as medically vulnerable people, amid a new rise in infections and hospitalisations across Europe.
While existing coronavirus vaccines continue to provide good protection against hospitalisation and death, vaccine effectiveness has taken a hit as the virus has evolved.
EU health agencies have since April recommended a second booster only for those older than 80 and the most vulnerable.
The new recommendation is expected to facilitate national decisions to speed up vaccination campaigns, which have been slowing to nearly a halt in recent months.
"We are currently seeing increasing COVID-19 case notification rates and an increasing trend in hospital and ICU admissions and occupancy in several countries mainly driven by the BA 5 sublineage of (the) Omicron (coronavirus variant)," said Andrea Ammon, the director of the European Centre for Disease Prevention and Control (ECDC), in a statement.
"This signals the start of a new, widespread COVID-19 wave across the European Union," she said, adding that giving the over 60s and medically vulnerable a second booster now would avert a significant number of hospitalisations and deaths.
Vaccine makers, such as Moderna (NASDAQ:MRNA) Inc and partners Pfizer Inc (NYSE:PFE) and BioNTech, have been testing versions of their COVID vaccines modified to combat the BA.1 Omicron variant.
Although they have said those vaccines generated a good immune response against BA.1 and the more recently circulating variants, they did see a lower response against BA.4 and BA.5.
The European Medicines Agency (EMA), which is currently reviewing two variant-adapted vaccines, expects to have the first next-generation vaccines approved by September.
"In the meantime, it is important to consider using currently authorised vaccines as second boosters in people who are most vulnerable," said EMA executive director Emir Cooke.
There is no clear evidence to support giving a second booster dose to people below 60 years of age who are not at higher risk of severe disease, the ECDC added on Monday.
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.